Nonsteroidal Anti-Inflammatory Drugs and Hypertension: The Risks in Perspective

Drugs

Volumn 51, Issue 2, 1996, Pages 179-187

  De Leeuw, Peter W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FENOPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PROSTAGLANDIN; SULINDAC;

ADRENERGIC ACTIVITY; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG SAFETY; EDITORIAL; EXTRACELLULAR SPACE; FLUID BALANCE; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; META ANALYSIS; NEPHROTOXICITY; PRESSORECEPTOR; RANDOMIZED CONTROLLED TRIAL; VASCULAR RESISTANCE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PRESSURE; HUMANS; HYPERTENSION; PROSTAGLANDINS; RISK;

EID: 0030068309     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199651020-00001     Document Type: Review

References (49)

1. McGiff JC, Crowshaw K, Terragno NA, et al. Release of a prostaglandin like substance into renal venous blood in response to angiotensin II. Circ Res 1970; 26/27 Suppl. 1: I-121-I-30
2. Quilley J, McGiff JC. Eicosanoids. In: Swales JD, editor. Textbook of hypertension. Oxford: Blackwell Scientific Publications, 1994: 314-27
3. Papanicolaou N, Mountakalakis N, Safar M, et al. Deficiency in renomedullary prostaglandin synthesis related to the evolution of essential hypertension. Experientia 1976; 32: 1015-6
4. Abe K, Yasujima S, Chiba N, et al. Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension. Prostaglandins 1977; 14: 513-21
5. Tan SY, Sweet P, Mulrow PJ. Impaired renal production of prostaglandin E2: a newly identified lesion in human essential hypertension. Prostaglandins 1978; 15: 139-49
6. Weber PC, Scherer B, Held E, et al. Urinary prostaglandins and kallikrein in essential hypertension. Clin Sci 1979; 57 Suppl. 5: 259s-61s
7. Hornych A, Safar M, Bariety J, et al. Thromboxane B2 in borderline and essential hypertensive patients. Prostaglandins Leukot Med 1983; 10: 145-55
8. Patak RV, Mookerjee BK, Bentzell CJ, et al. Antagonism of effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins 1975; 10: 649-59
9. Negus P, Tannen RL, Dunn MJ. Indomethacin potentiates the vasoconstrictor actions of angiotensin II in normal man. Prostaglandins 1976; 12: 175-80
10. Ylitelo P, Pitkäjärvi T, Metsä-Ketelä T, et al. The effect of inhibition of prostaglandin synthesis on plasma renin activity and blood pressure in essential hypertension. Prostaglandins Med 1978; 1: 479-88
11. Lopez-Ovejero JA, Weber MA, Drayer JIM, et al. Effects of indomethacin alone and during diuretic or beta-adreno-receptor blockade therapy on blood pressure and the renin system in essential hypertension. Clin Sci Mol Med 1978; 55 Suppl. 4: 203s-5s
12. Staessen J, Fagard R, Lijnen P, et al. Effects of prostaglandin synthesis inhibition on blood pressure and humoral factors in exercising, sodium-deplete normal man. J Hypertens 1983; 1: 123-30
13. Hardy BG, Bartle WR, Myers M, et al. Effect of indomethacin on the pharmacokinetics and pharmacodynamics of felodipine. Br J Clin Pharmacol 1988; 26: 557-62
14. Beckmann ML, Gerber JG, Byyny RL, et al. Propranolol increases prostacyclin synthesis in patients with essential hypertension. Hypertension 1988; 12: 582-8
15. Gerber JG, LoVerde M, Byyny RL, et al. The antihypertensive efficacy of hydrochlorothiazide is not prostacyclin dependent. Clin Pharmacol Ther 1990; 48: 424-30
16. Wright JT, McKenney JM, Lehany A, et al. The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazide. Clin Pharmacol Ther 1989; 46: 440-4
17. Cinquegrani MP, Liang CS. Antihypertensive effects of pinacidil in patients with and without indomethacin pretreatment. Clin Exp Hypertens 1988; 10: 411-31
18. Pedrinelli R, Magagna A, Salvetti A. The effect of oxprenolol and indomethacin on renin and aldosterone of normal subjects during low sodium diet. Eur J Clin Invest 1982; 12: 107-11
19. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993; 153: 477-84
20. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? Ann Intern Med 1994; 121: 289-300
21. Walter E, Kaufmann W, Oster P. Does chronic aspirin treatment increase blood pressure in man? Klin Wochenschr 1981; 59: 297-9
22. Chrischilles EA, Wallace RB. Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population. J Gerontol 1993; 48: M91-6
23. Johnson AG, Simons LA, Simons J, et al. Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmacol 1993; 35: 455-9
24. Gurwitz JH, Avorn J, Bohn RL, et al. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA 1994; 272: 781-6
25. Ferri C, Bellini C, Piccoli A, et al. Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension. Hypertension 1993; 21: 875-81
26. Watkins J, Abbott EC, Hensby CN, et al. Attenuation of the hypotensive effect of propranolol and thiazide diuretics by indomethacin. BMJ 1980; 281: 702-5
27. Koopmans PP, Thien Th. Gribnau FWJ. Influence of nonsteroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension. BMJ 1984; 289: 1492-4
28. Puddey IB, Beilin IJ, Vandongen R, et al. Differential effects of sulindae and indomethacin on blood pressure in treated essential hypertensive subjects. Clin Sci 1985; 69: 327-36
29. Chalmers JP, West MJ, Wing LMH, et al. Effects of indomethacin, sulindae, naproxen, aspirin, and paracetamol in treated hypertensive patients. Clin Exp Hypertens 1984; A6: 1077-93
30. Koopmans PP, Thien Th. Gribnau FWJ. The influence of ibuprofen, diclofenac and sulindac on the blood pressure lowering effect of hydrochlorothiazide. Eur J Clin Pharmacol 1987; 31: 553-7
31. Wong DG, Spence JD, Lamki L, et al. Effect of non-steroidal anti-inflammatory drugs on control of hypertension by beta-blockers and diuretics. Lancet 1986; 1: 997-1001
32. Oates JA. Antagonism of antihypertensive drug therapy by non-steroidal anti-inflammatory drugs. Hypertension 1988; Suppl. II: II-4-6
33. Durao V, Prata MM, Gonsalves LMP. Modification of antihypertensive effect of beta-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis. Lancet 1977; 2: 1005-7
34. Salvetti A, Arzili F, Pedrinelli R, et al. Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients. Eur J Clin Pharmacol 1982; 22: 197-201
35. Rubin P, Jackson G, Blashke T. Studies of the clinical pharmacology of prazosin: II. The influence of indomethacin and of propranolol on the action and disposition of prazosin. Br J Clin Pharmacol 1980; 10: 33-9
36. Salvetti A, Abdel-Haq B, Magagna A, et al. Indomethacin reduces the antihypertensive action of enalapril. Clin Exp Hypertens 1987; 9: 559-67
37. Salvetti A, Pedrinelli R, Magagna A, et al. Differential effects of selective and non-selective prostaglandin synthesis inhibition on the pharmacological responses to captopril in patients with essential hypertension. Clin Sci 1982; 63 Suppl. 8: S261-3
38. Reimann IW, Ratge D, Wisser H, et al. Influence of prostaglandin inhibition on dihydralazine-induced acute effects in patients with essential hypertension. Clin Exp Pharmacol Physiol 1985; 12: 79-89
39. Schoenfeld A, Freedman S, Hod M, et al. Antagonism of antihypertensive drug therapy in pregnancy by indomethacin? Am J Obstet Gynecol 1989; 161: 1204-5
40. Radack KL, Deck CC. Do nonsteroidal anti-inflammatory drugs interfere with blood pressure control in hypertensive patients? J Gen Intern Med 1987; 2: 108-12
41. Sedor JR, Williams SL, Chremos AN, et al. Effects of sulindac and indomethacin on renal prostaglandin synthesis. Clin Pharmacol Ther 1984; 36: 85-91
42. Wennmalm A. Influence of indomethacin on the systemic and pulmonary vascular resistance in man. Clin Sci Mol Med 1978; 54: 141-5
43. Safar ME, Hornych AF, Levenson JA, et al. Central haemodynamics and plasma prostaglandin E2 in borderline and sustained essential hypertensive patients before and after indomethacin. Clin Sci 1981; 61 Suppl. 7: 323s-5s
44. Nowak J, Wennmalm A. Influence of indomethacin and of prostaglandin E1 on total and regional blood flow in man. Acta Physiol Scand 1978; 102: 484-91
45. Cowley AJ, Stainer K, Rowley JM, et al. Effect of aspirin and indomethacin on exercise-induced changes in blood pressure and limb blood flow in normal volunteers. Cardiovasc Res 1985; 19: 177-80
46. Kilbom A, Wennmalm A. Endogenous prostaglandins as local regulators of blood flow in man: effect of indomethacin on reactive and functional hyperemia. J Physiol 1976; 257: 109-21
47. Clive DM, Stoff JS. Renal syndromes associated with non-steroidal antiinflammatory drugs. N Engl J Med 1984; 310: 563-72
48. Donker AJM, Arisz L, Brentjens JRH, et al. The effect of indomethacin on kidney function and plasma renin activity in man. Nephron 1976; 17: 288-96
49. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74